idiopathic pleuroparenchymal fibroelastosis: a rare but increasingly recognized entity

Clicks: 131
ID: 173201
2015
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #13 of 23 articles by views in international journal of performability engineering

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is a recently described rare entity, characterized by pleural and subpleural parenchymal fibrosis and elastosis mainly in the upper lobes. The etiology and pathophysiology are unknown. The prognosis is poor, with no effective therapies other than lung transplantation. IPPFE should be properly identified so that it can be approached correctly. This report describes two clinical cases with clinical imaging and histological features compatible with IPPFE. Keywords: Interstitial lung disease, Pleuroparenchymal fibrosis, Fibroelastosis
Reference Key
redondo2015revistaidiopathic Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;M.T. Redondo;N. Melo;P.C. Mota;J.M. Jesus;C.S. Moura;S. Guimarães;A. Morais
Journal international journal of performability engineering
Year 2015
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.